Search NLS News

Oncopeptides has announced that the US Food and Drug Administration, FDA, has requested a withdrawal of the US marketing authorization for Pepaxto. The request is based on the outcome of the confirmatory phase 3 OCEAN study, which demonstrated an ITT overall survival HR of 1.1, but with significant survival result differences for both melflufen and […]

This year’s SwedenBIO Award was given to the imaging technology company Antaros Medical, for their innovative imaging solution that aids the understanding of how medicines work in the human body. Antaros Medical’s CEO and co-founder Johannes Hulthe received the SwedenBIO Award on December 6, in a prize ceremony held in connection with this year’s SwedenBIO […]

Evaxion Biotech has signed a Vaccine Discovery Collaboration Agreement with ExpreS2ion Biotech Holding’s affiliate ExpreS2ion Biotechnologies for the joint development of a novel cytomegalovirus (CMV) vaccine candidate. During the discovery phase of the collaboration, Evaxion will use its proprietary AI platform, RAVEN, to design a next-generation vaccine candidate that elicits both cellular and humoral/antibody responses. […]

The new Chief Medical Officer, Pia Baumann’s, role includes overall responsibility for the continued clinical development of the candidate drug fostroxacitabine bralpamide. She will be part of the company’s management team and will take up her position on February 20, 2023. “Her experience in global drug development as well as interaction and cooperation with regulatory […]

Spago Nanomedical has received regulatory approval to initiate a Phase IIa clinical study with its MRI contrast agent SN132D in endometriosis. Patient recruitment has started, and the first patient is expected to be dosed shortly. The ongoing SPAGOPIX-01 study in breast cancer has now been concluded and a final report is in preparation, states the […]

It is once again time to honor extraordinary scientific discoveries. Welcome to our 15th Nobel Prize coverage! We have covered the announcements, written about the discoveries and interviewed the Nobel Laureates since 2008 – and this year is no exception! Read about the 2022 Nordic Laureates, the Medicine and Chemistry discoveries, as well as highlights from […]

AstraZeneca has announces the sale of its West Chester site in Ohio, US, to National Resilience, a technology-focused manufacturing company dedicated to broadening access to complex medicines. “As part of our long-term strategy to ensure our global supply network remains fit for the future, we are continuously optimizing our manufacturing footprint to meet the evolving […]

AstraZeneca has announced an agreement to acquire Neogene Therapeutics, a global clinical-stage biotechnology company focusing on the discovery, development and manufacturing of next-generation T-cell receptor therapies (TCR-Ts) that offer a novel cell therapy approach for targeting cancer. With a shared goal of bringing cell therapies to patients with solid tumors, Neogene’s expertise in TCR-T discovery, […]

Prothya Biosolutions Finland Oy is a subsidiary of Prothya Biosolutions, which was formed in 2021, when Plasma Industries Belgium integrated with Sanquin Plasma Products, a former subsidiary of the Sanquin Blood Supply Foundation. Prothya Biosolutions produces life-saving plasma-derived medicinal products for use in immunology and critical care. Prothya Biosolutions offers over 60 years of experience in […]

Are you an experienced Medical Manager looking for a new challenge in which you can grow your skills and knowledge while making a difference to patients? – Then this job will be perfect for you. Boehringer Ingelheim is one of the world’s top 20 pharmaceutical companies. At Boehringer Ingelheim we develop breakthrough therapies that improve the […]